Trials / Completed
CompletedNCT04819646
Evaluate the Effects of a Marine Lipid Oil Concentrate Formulation on Inflammation/Discomfort
An Open-label, Single-arm Study to Evaluate the Effects of a Marine Lipid Oil Concentrate Formulation on Inflammation/Discomfort in Individuals Who Are Generally Healthy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Supplement Formulators, Inc. · Industry
- Sex
- All
- Age
- 35 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to assess the efficacy and safety of a Marine Lipid Oil Concentrate formulation on inflammation/discomfort and overall well-being in male and female subjects who are generally healthy
Detailed description
This is an open-label, single-arm remote study to evaluate the effects of a Marine Lipid Oil Concentrate formulation on inflammation/discomfort and overall well-being in individuals who are generally healthy. Each subject will receive a specific dose of the study products to be taken once daily for a total of 60 days. Participants complete assessments and questionnaires. The primary objective is the evaluation of the change in the responses to the SF-36 (Short-Form-36) Health Survey, Medical Symptoms questionnaire, Pain questionnaire and responses on an assessment form relative to baseline. Safety and tolerability will be evaluated through receipt of documentation and responses from the telephone contacts/emails as per protocol.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Marine Lipid Oil Concentrate Formulation | Marine Lipid Oil Concentrate softgels |
| DIETARY_SUPPLEMENT | Dietary Supplement | Dietary Supplement capsules |
Timeline
- Start date
- 2021-01-07
- Primary completion
- 2021-09-03
- Completion
- 2021-11-02
- First posted
- 2021-03-29
- Last updated
- 2023-01-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04819646. Inclusion in this directory is not an endorsement.